![]() Factors that negatively affected growth in the historic period were high cost, low rates of IVF success, congenital abnormality occurrence and risks and side effects associated with IVF. Growth in the historic period resulted from increasing prevalence of PCOS (Polycystic ovary syndrome) condition, premature ovarian failure, increasing rate of male infertility and insurance coverages to IVF procedures. It covers three five-year periods including, 2015 to 2020, termed the historic period, 2020 through 2025, the forecast period, and 2025-2030 the forecast period. This report describes and evaluates the global fertility services market. The global fertility services market is expected to reach $161,846.9 million in 2030, at a CAGR of 15.7%. The market is expected to grow at a CAGR of 15.7% from 2020 to reach $78,201.7 million in 2025. The global fertility services market is expected to grow from $24,466.2 million in 2015 to $37,773.7 million in 2020 at a compound annual growth rate (CAGR) of 9.1%. ![]() Use of these names, logos and brands does not imply endorsement.DUBLIN-( BUSINESS WIRE)-The "Fertility Services Global Market Opportunities And Strategies To 2030, By Procedure, Service, Application" report has been added to 's offering. All company, product and service names used in this communication are for identification purposes only. All product names, logos and brands are property of their respective owners. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. WellSky, leading health and community care technology company, has announced its acquisition of Experience Care, provider of a suite of software solutions for post-acute and long-term care providers.Travel Nurse Across America (TNAA), announced their acquisition of Stogo, an innovative health system shift management platform.Timber Pharmaceuticals, a clinical-stage biopharmaceutical company, has agreed to be acquired by LEO Pharma, a medical dermatology company, for a total transaction value of up to $36M.Thyme Care, provider of value-based cancer care services, has secured $60M in a series B fundraise co-led by Town Hall Ventures and Foresite Capital alongside participation from current investors.Madison Dearborn Partners portfolio company Solis Mammography, a provider of specialized breast health services including an AI-driven diagnostic tool, has acquired Carolina Breast Imaging, a network of three breast imaging centers.Sanuwave Health, provider of next-generation wound care products, announced a planned business combination with SEP Acquisition Corp where the combined company is anticipated to trade on the Nasdaq Capital Market.Reproductive Medicine Associates, a New Jersey-based provider of fertility solutions has acquired Conceptions Reproductive Associates of Colorado. RMA is owned by IVI-RMA Global.Princeton Medspa Partners has acquired its sixth physician-owned medical spa, Advanced Life Clinic, a Huntsville-based aesthetic medical practice.Ovation Healthcare, provider of shared services, announced a merger with 3D Technology, a technology provider of professional and managed services to assist hospitals improve clinical efficiencies and patient experience.Nutex Health Inc., a tech-integrated healthcare delivery system, has announced acquisitions of Florida-based independent practice associations, Population Health Associates and Managed Care Insurance Consultants, which will assist in expanding their existing client-base.Nursa, a nationwide platform that exists to put a nurse at the bedside of every patient in need quickly and safely, removing the financial strain and operational gaps of traditional staffing methods, has raised $80M in series B funding led by Drive Capital in addition to existing partners.HealthDrive, a multi-specialty clinical services organization to patients residing in long-term care facilities, was acquired by Cressey & Company.Genesis Therapeutics, provider of AI technologies used to create medicines for severe diseases, has closed a $200M series B financing co-led by a U.S.-based life-sciences-focused investor and returning investor Andreessen Horowitz (a16z) Bio + Health in addition to several other investors.Enhabit Home Health & Hospice confirms exploration of strategic alternatives to enhance stockholder value.TripleTree’s Healthcare M&A Weekly summarizes recent activity and highlights the industry transactions shaping the future of healthcare. The healthcare industry is rapidly evolving, with the lines betweeen the healthcare technology and services sectors blurring – creating the catalyst for innovation, transformation, and continued market activity.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |